TENSILON Drug Patent Profile
✉ Email this page to a colleague
When do Tensilon patents expire, and what generic alternatives are available?
Tensilon is a drug marketed by Pai Holdings Pharm and is included in one NDA.
The generic ingredient in TENSILON is edrophonium chloride. There are three drug master file entries for this compound. Additional details are available on the edrophonium chloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TENSILON?
- What are the global sales for TENSILON?
- What is Average Wholesale Price for TENSILON?
Summary for TENSILON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 26 |
Clinical Trials: | 1 |
Patent Applications: | 3,418 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TENSILON at DailyMed |
![TENSILON drug patent expirations Drug patent expirations by year for TENSILON](/p/graph/s/t/TENSILON-patent-expirations.png)
Recent Clinical Trials for TENSILON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Diego | N/A |
US Patents and Regulatory Information for TENSILON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pai Holdings Pharm | TENSILON | edrophonium chloride | INJECTABLE;INJECTION | 007959-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pai Holdings Pharm | TENSILON PRESERVATIVE FREE | edrophonium chloride | INJECTABLE;INJECTION | 007959-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |